Eloxx Pharmaceuticals Acquires Zikani, Will Further CF Program and More,

Now, the ongoing Phase 2 clinical trials — EL-012 (NCT04135495) and EL-004 (NCT04126473) — are testing the safety, tolerability, and …, Now, the ongoing Phase 2 clinical trials — EL-012 (NCT04135495) and EL-004 (NCT04126473) — are testing the safety, tolerability, and …, Read More

Scroll to Top